Alpha Intelligence Capital

Tracked participation in 2 Atlas companies, with 1 explicitly attributed lead.

2portfolio companies

2round participations

1lead positions

$33Mled round total

Conviction

Most recent leads

The latest rounds this investor is sourced as leading, newest first.

Mar 2026OwkinSpin-out financing: Waiv (formerly Owkin Dx)$33M

Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleAttributed partner

OOwkinScienceOwkin is a privately held AI company building “agentic” biological AI products for drug discovery, clinical…$1Bvaluation$635.2MraisedRecent roundsTotal disclosed (company press kit aggregate) · null$304.1M · Bpifrance Large Ventures, Bristol-Myers Squibb +10Spin-out financing: Waiv (formerly Owkin Dx) · Mar 2026$33M · led by Alpha Intelligence Capital, OTB VenturesStrategic collaboration with Bristol Myers Squibb (incl. Series B-1 equity investment) · Jun 2022$80M · led by Bristol Myers SquibbOwkin—Mar 2026 → Mar 20261 round1 led—

ALAMI Labs$3BMar 2026 → Mar 20261 roundParticipant—

DateCompanyRoundRaisedValuationRoleEvidence

Mar 12, 2026OOwkinScienceOwkin is a privately held AI company building “agentic” biological AI products for drug discovery, clinical…$1Bvaluation$635.2MraisedRecent roundsTotal disclosed (company press kit aggregate) · null$304.1M · Bpifrance Large Ventures, Bristol-Myers Squibb +10Spin-out financing: Waiv (formerly Owkin Dx) · Mar 2026$33M · led by Alpha Intelligence Capital, OTB VenturesStrategic collaboration with Bristol Myers Squibb (incl. Series B-1 equity investment) · Jun 2022$80M · led by Bristol Myers SquibbOwkinSpin-out financing: Waiv (formerly Owkin Dx)$33M—Lead

Source ↗

Mar 10, 2026ALAMI LabsSeed (official launch / first disclosed round)$1B$3BParticipant

Source ↗+1 ↗

DateCompanyRoundRaisedValuationRoleEvidence

Mar 10, 2026ALAMI LabsSeed (official launch / first disclosed round)$1B$3BParticipant

Source ↗+1 ↗

Source ↗